Leadership Overview
Globus Medical has 4 executives leading key functions including strategy, technology, finance, and product lines.
Driven by a mission to enable pain-free, active lives, Globus Medical leverages superior engineering and technology to advance surgical solutions, positioning itself as a leader in the musculoskeletal solutions sector.
Driven by a mission to enable pain-free, active lives, Globus Medical leverages superior engineering and technology to advance surgical solutions, positioning itself as a leader in the musculoskeletal solutions sector.
Leadership Roles at Globus Medical
Keith Pfeil - President & Chief Executive Officer
Keith Pfeil, the President & Chief Executive Officer at Globus Medical, directs the company's overall strategy and operational execution. Pfeil guides the organization's mission to advance surgery and achieve pain-free, active lives for patients through technological innovation. Overseeing all business units, the President & Chief Executive Officer ensures alignment with the company's rapid growth trajectory in the musculoskeletal solutions market. This leadership role involves driving the strategic vision that has established Globus Medical as the fastest-growing company in orthopedic history. By fostering a culture of continuous improvement, Keith Pfeil ensures the company maintains its competitive edge and delivers exceptional value to stakeholders and patients alike. The President & Chief Executive Officer's focus remains on expanding the company's technological capabilities and market reach.

Kyle Kline - Senior Vice President & Chief Financial Officer
Kyle Kline, the Senior Vice President & Chief Financial Officer at Globus Medical, manages the company's financial strategy and fiscal operations. Kline oversees all aspects of financial planning, accounting, and investor relations, ensuring robust financial health and supporting the company's aggressive growth initiatives. This executive position is crucial for maintaining the financial stability required to fund Globus Medical's continuous technological advancements and market expansion. The Senior Vice President & Chief Financial Officer directs capital allocation to support research and development, manufacturing, and global sales efforts. By providing strategic financial insights, Kyle Kline enables informed decision-making across all departments. The Senior Vice President & Chief Financial Officer's stewardship ensures the company's financial performance aligns with its mission to provide advanced musculoskeletal solutions and achieve significant market leadership.
David Hole - Global President, Spine
David Hole, the Global President, Spine at Globus Medical, leads the strategic direction and commercial success of the company's spine product division. Hole drives the expansion of the spine portfolio, focusing on innovative solutions that address a wide range of spinal conditions and improve patient mobility. This leadership position involves overseeing global sales, marketing, and product development efforts specifically for spine-related technologies. The Global President, Spine ensures that the division's offerings align with Globus Medical's overarching goal of advancing surgery and enabling active lives. By fostering strong relationships with healthcare providers and key opinion leaders, David Hole strengthens the company's market presence in the critical spine segment. The Global President, Spine's expertise is instrumental in maintaining the division's rapid growth and technological leadership within the orthopedic industry.

Norbert Johnson - Chief Technology Officer, Imaging, Navigation & Robotics
Norbert Johnson, the Chief Technology Officer, Imaging, Navigation & Robotics at Globus Medical, architects the company's technological roadmap for advanced surgical solutions. Johnson spearheads the development and integration of cutting-edge imaging, navigation, and robotics systems that enhance surgical precision and patient outcomes. This critical role involves overseeing research and development initiatives, ensuring that Globus Medical remains at the forefront of innovation in the musculoskeletal sector. The Chief Technology Officer, Imaging, Navigation & Robotics drives the engineering efforts that translate complex technological concepts into practical, impactful surgical tools. By collaborating with product development teams, Norbert Johnson ensures that new technologies directly support the company's mission of enabling pain-free, active lives. The Chief Technology Officer, Imaging, Navigation & Robotics's expertise is vital for maintaining the company's status as a leader in orthopedic technology.
Explore Leadership Teams in Manufacturing
National Dentex Labs provides dental prosthetics, restorative dental products, and other dental services. Their products and services include dentures and partials, crowns, implants, appliances, and orthodontics. The company is headquartered in Palm Beach Gardens, Florida, and was founded in 1982.
Company Leadership DW
TS
RM
JB
BD is widely perceived as a global medical technology company that develops and manufactures medical devices, diagnostic systems, laboratory equipment, and healthcare solutions. The company supports hospitals, laboratories, and healthcare providers through innovations in patient safety, drug delivery, diagnostics, and biosciences.
Company Leadership


ND
ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership



ICU Medical has consistently provided you with clinical innovations that help solve real-world challenges. With the acquisition of Hospira Infusion Systems in 2017 and Smiths Medical in 2022, we are now a global market leader with a complete line of clinically-essential IV therapy and high-value critical care products for hospital, alternate site, and home care settings. We're ready to bring you consistent quality, innovation, and value in more areas than ever.
Company Leadership DW
JC
